These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7477581)

  • 21. Influenza vaccine 2008-2009.
    Med Lett Drugs Ther; 2008 Oct; 50(1296):77-9. PubMed ID: 18833032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bullous pemphigoid triggered by influenza vaccination? Ecological study in Galicia, Spain.
    García-Doval I; Mayo E; Nogueira Fariña J; Cruces MJ
    Br J Dermatol; 2006 Oct; 155(4):820-3. PubMed ID: 16965434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza vaccine adverse event and effect on acceptability in pediatric residents.
    Kara A; Devrim I; Celik T; Akca T; Tezer H; Simsek OP; Kutluk T; Kale G; Secmeer G
    Jpn J Infect Dis; 2007 Nov; 60(6):387-8. PubMed ID: 18032840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Is there a benefit from an early booster vaccination in the control of equine influenza?
    Heldens JG; van Loon AA; van de Zande S
    Vet J; 2007 Nov; 174(3):592-8. PubMed ID: 17560150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3-14-year-olds.
    Rudenko LG; Lonskaya NI; Klimov AI; Vasilieva RI; Ramirez A
    Bull World Health Organ; 1996; 74(1):77-84. PubMed ID: 8653819
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influenza vaccination in patients with cirrhosis and in liver transplant recipients.
    Gaeta GB; Pariani E; Amendola A; Brancaccio G; Cuomo G; Stornaiuolo G; Zappa A; Zanetti A
    Vaccine; 2009 May; 27(25-26):3373-5. PubMed ID: 19200844
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza vaccination in patients with breast cancer: a case-series analysis.
    Vilar-Compte D; Cornejo P; Valle-Salinas A; Roldán-Marin R; Iguala M; Cervantes Y; López I
    Med Sci Monit; 2006 Aug; 12(8):CR332-6. PubMed ID: 16865064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Validity of parental report of influenza vaccination in children 6 to 59 months of age.
    Shinall MC; Plosa EJ; Poehling KA
    Pediatrics; 2007 Oct; 120(4):e783-7. PubMed ID: 17908736
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute febrile neutrophilic dermatosis (Sweet's syndrome) after influenza vaccination.
    Jovanović M; Poljacki M; Vujanović L; Duran V
    J Am Acad Dermatol; 2005 Feb; 52(2):367-9. PubMed ID: 15692491
    [No Abstract]   [Full Text] [Related]  

  • 30. Pancolitis after influenza vaccination.
    Luca L; Morisset M; Kanny G; Moneret-Vautrin DA
    Allergy; 2004 Mar; 59(3):367. PubMed ID: 14982531
    [No Abstract]   [Full Text] [Related]  

  • 31. Post-influenza vaccine chronic inflammatory demyelinating polyneuropathy.
    Brostoff JM; Beitverda Y; Birns J
    Age Ageing; 2008 Mar; 37(2):229-30. PubMed ID: 17993473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of influenza vaccination in systemic lupus erythematosus patients with quiescent disease.
    Holvast A; Huckriede A; Wilschut J; Horst G; De Vries JJ; Benne CA; Kallenberg CG; Bijl M
    Ann Rheum Dis; 2006 Jul; 65(7):913-8. PubMed ID: 16322083
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of rapidly progressive HTLV-I-associated myelopathy (HAM)].
    Kida H; Nakagawa M; Iwasaki H; Moritoyo T; Kawabata M; Arimura K; Osame M
    Rinsho Shinkeigaku; 1997 Sep; 37(9):802-5. PubMed ID: 9430994
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and immunogenicity of two subunit influenza vaccines in healthy children, adults and the elderly: a randomized controlled trial in China.
    Zhu FC; Zhou W; Pan H; Lu L; Gerez L; Nauta J; Giezeman K; de Bruijn I
    Vaccine; 2008 Aug; 26(35):4579-84. PubMed ID: 18602729
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refractory thrombotic thrombocytopenic purpura following influenza vaccination.
    Dias PJ; Gopal S
    Anaesthesia; 2009 Apr; 64(4):444-6. PubMed ID: 19317713
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.
    Mullooly JP; Crane B; Chun C
    Vaccine; 2006 Mar; 24(13):2256-63. PubMed ID: 16375995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunomodulating effect of influenza vaccination in the elderly differing in health status.
    Myśliwska J; Trzonkowski P; Szmit E; Brydak LB; Machała M; Myśliwski A
    Exp Gerontol; 2004 Oct; 39(10):1447-58. PubMed ID: 15501014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Assessment of efficacy and economic impact of an influenza vaccination campaign in the personnel of a health care setting].
    Cella MT; Corona G; Tuccillo E; Franco G
    Med Lav; 2005; 96(6):483-9. PubMed ID: 16983973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Early adverse reactions after vaccination against influenza in chronically ill people].
    Gałaj A; Grześk G; Kuziemski A; Szadujkis-Szadurski L; Durmowicz A
    Wiad Lek; 2002; 55(7-8):366-72. PubMed ID: 12428564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systemic vasculitis following influenza vaccination--report of 3 cases and literature review.
    Mader R; Narendran A; Lewtas J; Bykerk V; Goodman RC; Dickson JR; Keystone EC
    J Rheumatol; 1993 Aug; 20(8):1429-31. PubMed ID: 8230034
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.